Evidence map›Paper›PMID 30285840›Full record

ArticleBMC research notes2018

Codon-optimized DsRed fluorescent protein for use in Mycobacterium tuberculosis.

Paul Carroll, Julian Muwanguzi-Karugaba, Tanya Parish

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Paul CarrollQueen Mary University of London, Barts & The London School of Medicine and Dentistry, London, UK.
Julian Muwanguzi-KarugabaQueen Mary University of London, Barts & The London School of Medicine and Dentistry, London, UK.
Tanya ParishQueen Mary University of London, Barts & The London School of Medicine and Dentistry, London, UK. Tanya.Parish@idri.org.ORCID http://orcid.org/0000-0001-7507-0423
Queen Mary University of London · GBInfectious Disease Research Institute · US

Funding

Bill and Melinda Gates Foundation OPP42786
6 · The paper itself

Abstract

objectiveWe have previously codon-optimized a number of red fluorescent proteins for use in Mycobacterium tuberculosis (mCherry, tdTomato, Turbo-635). We aimed to expand this repertoire to include DsRed, another widely used and flexible red fluorescent protein.

resultsWe generated expression constructs with a full length DsRed under the control of one of three strong, constitutive promoters (P

Indexed as

CodonGenes, ReporterLuminescent ProteinsMycobacterium tuberculosisRed Fluorescent ProteinCodonfluorescent protein 583Luminescent ProteinsRed Fluorescent ProteinFluorescent proteinMycobacteriaReporter system

Identifiers

PMID30285840
PMCPMC6167837
OpenAlexW2892538819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.